425 related articles for article (PubMed ID: 30684657)
1. Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms.
Shi NQ; Wang SR; Zhang Y; Huo JS; Wang LN; Cai JH; Li ZQ; Xiang B; Qi XR
Eur J Pharm Sci; 2019 Mar; 130():78-90. PubMed ID: 30684657
[TBL] [Abstract][Full Text] [Related]
2. Self-micellizing solid dispersions enhance the properties and therapeutic potential of fenofibrate: Advantages, profiles and mechanisms.
Shi NQ; Zhang Y; Li Y; Lai HW; Xiao X; Feng B; Qi XR
Int J Pharm; 2017 Aug; 528(1-2):563-577. PubMed ID: 28602799
[TBL] [Abstract][Full Text] [Related]
3. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
4. Tailored Supersaturable Immediate Release Behaviors of Hypotensive Supersaturating Drug-Delivery Systems Combined with Hot-Melt Extrusion Technique and Self-Micellizing Polymer.
Yu H; Ma Y; Zhang Y; Zhang H; Zuo L; Hao C; Yu W; Lin X; Zhang Y; Qi X; Shi N
Polymers (Basel); 2022 Nov; 14(22):. PubMed ID: 36432925
[TBL] [Abstract][Full Text] [Related]
5. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
[TBL] [Abstract][Full Text] [Related]
6. Hot Melt Extrusion-Triggered Amorphization as a Continuous Process for Inducing Extended Supersaturable Drug Immediate-Release from saSMSDs Systems.
Yu H; Zhang Y; Ma Y; Zhang H; Hao C; Zhang Y; Li Z; Qi X; Shi N
Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456600
[TBL] [Abstract][Full Text] [Related]
7. Improved oral absorption profile of itraconazole in hypochlorhydria by self-micellizing solid dispersion approach.
Kojo Y; Matsunaga S; Suzuki H; Sato H; Seto Y; Onoue S
Eur J Pharm Sci; 2017 Jan; 97():55-61. PubMed ID: 27810562
[TBL] [Abstract][Full Text] [Related]
8. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
9. Predicting physical stability of ternary amorphous solid dispersions using specific mechanical energy in a hot melt extrusion process.
Hanada M; Jermain SV; Lu X; Su Y; Williams RO
Int J Pharm; 2018 Sep; 548(1):571-585. PubMed ID: 30006310
[TBL] [Abstract][Full Text] [Related]
10. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
[TBL] [Abstract][Full Text] [Related]
11. Bottom-Up and Top-Down Approaches to Explore Sodium Dodecyl Sulfate and Soluplus on the Crystallization Inhibition and Dissolution of Felodipine Extrudates.
Chen J; Chen Y; Huang W; Wang H; Du Y; Xiong S
J Pharm Sci; 2018 Sep; 107(9):2366-2376. PubMed ID: 29738699
[TBL] [Abstract][Full Text] [Related]
12. Interdependence of particle properties and bulk powder behavior of indomethacin in quench-cooled molten two-phase solid dispersions.
Semjonov K; Salm M; Lipiäinen T; Kogermann K; Lust A; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
Int J Pharm; 2018 Apr; 541(1-2):188-197. PubMed ID: 29481945
[TBL] [Abstract][Full Text] [Related]
13. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
14. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
Sarode AL; Sandhu H; Shah N; Malick W; Zia H
Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
[TBL] [Abstract][Full Text] [Related]
15. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
16. Drug-Smectite Clay Amorphous Solid Dispersions Processed by Hot Melt Extrusion.
Nandi U; Mithu MSH; Hurt AP; Trivedi V; Douroumis D
AAPS PharmSciTech; 2020 Oct; 21(7):276. PubMed ID: 33033890
[TBL] [Abstract][Full Text] [Related]
17. Effect of preparation method on the surface properties and UV imaging of indomethacin solid dispersions.
Asare-Addo K; Alshafiee M; Walton K; Ward A; Totea AM; Taheri S; Mawla N; Adebisi AO; Elawad S; Diza C; Timmins P; Conway BR
Eur J Pharm Biopharm; 2019 Apr; 137():148-163. PubMed ID: 30836178
[TBL] [Abstract][Full Text] [Related]
18. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach.
Patil H; Feng X; Ye X; Majumdar S; Repka MA
AAPS J; 2015 Jan; 17(1):194-205. PubMed ID: 25344439
[TBL] [Abstract][Full Text] [Related]
19. Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions.
Lu J; Cuellar K; Hammer NI; Jo S; Gryczke A; Kolter K; Langley N; Repka MA
Drug Dev Ind Pharm; 2016; 42(3):485-96. PubMed ID: 26530290
[TBL] [Abstract][Full Text] [Related]
20. Effects of preparing techniques and aging on dissolution behavior of the solid dispersions of NF/Soluplus/Kollidon SR: identification and classification by a combined analysis by FT-IR spectroscopy and computational approaches.
Li X; Jiang C; Pan L; Zhang H; Hu L; Li T; Yang X
Drug Dev Ind Pharm; 2015 Jan; 41(1):2-14. PubMed ID: 25026247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
